Sysmex America, Inc.

Sysmex America, Inc., a foreign-owned manufacturer and distributor of clinical laboratory diagnostic equipment headquartered in Lincolnshire, Illinois, operates as a large-business prime contractor delivering hematology analyzers, urinalysis systems, reagents, controls, calibration kits, and comprehensive maintenance and technical support services to federal healthcare agencies without small business set-aside designation. The company competes predominantly in the open federal marketplace under primary NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and secondary NAICS 339112 (Surgical Appliance and Supplies Manufacturing), with primary PSC concentration in Laboratory Equipment and Supplies (PSC 6520).

Sysmex America anchors its federal work on the GSA Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III), a $30.97 million contract effective through December 14, 2029 that has generated 1,728 task orders valued at $656.7 million in combined potential value across federal healthcare agencies. Representative work includes a $9.63 million delivery order from the Defense Health Agency for cost-per-reportable-test and cost-per-reportable-result hematology analyzer services (awarded October 1, 2025, completion September 30, 2030); a $1.625 million delivery order from Veterans Integrated Service Network 7 for automated hematology analyzers at Charleston, South Carolina (awarded January 1, 2026, completion December 31, 2030); and a $1.4 million delivery order from Veterans Integrated Service Network 5 for hematology instrumentation at Baltimore/Perry Point VA Medical Centers (awarded August 1, 2026, completion July 31, 2031). The company also holds multiple single-award BPAs with individual VISN networks: VISN 8 ($29.1 million ceiling through September 30, 2030), VISN 12 (implied multi-million-dollar concentration), VISN 19 ($7.74 million through December 31, 2026), VISN 2 ($3.62 million through September 30, 2030), and VISN 1 ($7.31 million through September 30, 2031).

Customer concentration is overwhelmingly tilted toward the Department of Veterans Affairs. The top five customers by potential value—VISN 12, VISN 9, Defense Health Agency, VISN 8, and VISN 10—account for 61 percent of combined potential value. By award count, the ranking shifts: Indian Health Service (562 awards, $35.9 million), DLA Troop Support Medical (351 awards, $713 thousand), VISN 23 (250 awards, $44 million), VISN 12 (236 awards, $573.4 million), and VISN 10 (234 awards, $50.1 million) represent 38 percent of all awards. The divergence reflects Sysmex's strategy of high-volume, smaller-value BPA calls with Indian Health Service and Defense Logistics Agency alongside larger, multi-year delivery orders with VISN networks, where cost-per-reportable-result and cost-per-test pricing models dominate.

Sysmex places task orders under the Critical Analyzers, Laboratory schedule (1,728 orders, $656.7 million), the Federal Supply Schedule V797P4709A (1,030 orders, $149.8 million), and the Multiple Award Schedule (264 orders, $23.4 million). The company also maintains numerous single-award BPAs with individual VISN networks serving as subordinate IDVs to the GSA Schedule, enabling streamlined procurement of equipment and consumables without full-and-open competition. Category concentration by award count reflects the business model: Analytical Laboratory Instrument Manufacturing (2,425 awards), Surgical Appliance and Supplies Manufacturing (319 awards), and In-Vitro Diagnostic Substance Manufacturing (196 awards) dominate the NAICS footprint, while Laboratory Equipment and Supplies (1,212 awards) and In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (709 awards) anchor the PSC profile.

Recent activity has remained stable at 250+ awards per year (2022–2025), with 131 awards recorded through mid-2026. One hundred fifty-three awards carrying combined potential value of $44.7 million face ultimate completion within the next twenty-four months, creating recompete exposure and opportunity for competitors on both VA and civilian agency labor-intensive service contracts. Sysmex America operates with negligible subcontract footprint (one sub-award to KBR Wyle Services for a hematology analyzer under HHPC2); nearly all federal work flows through prime contracting positions. The company has served 81 distinct federal agencies since its first recorded award in September 1996, though the portfolio concentrates heavily on VA health networks and Defense Health Agency across military medical treatment facilities, reflecting its established role as a primary supplier of automated laboratory diagnostics infrastructure to the federal healthcare enterprise.